Showing 1 results for Countermeasures
The goal of the NOW program is to develop a mobile medical countermeasure
(MCM) manufacturing platform for use in stabilization and humanitarian
operations to produce, formulate, and package hundreds of doses of nucleic
acid therapeutics (DNA and/or RNA) in less than 24 hours. The developed
platform should be a resilient, mobile, readily accessible nucleic acid MCM
manufacturing capability that enables immediate threat response anywhere the
military operates with minimal user intervention.